Finland· FI-REL-REL1526

Netilyn

A netilmicin product containing netilmicin sulfate, registered in Finland by Schering-Plough Europe. The same ATC class is registered in 3 of our 19 countries.

ATC J01GB07

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNetilynATCJ01GB07REGISTER NO.FI-REL-REL1526PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Netilmicin is registered in 3 of 19 countries.

Countries holding a registration under ATC J01GB07 (netilmicin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Netilmicin · ATC J01GB07

3 / 19 countries

  • Finlandprice
  • Italyprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Netilmicin sulfate
Manufacturer
Schering-Plough Europe
Country
Finland (FI)
ATC code
J01GB07
ATC class
Netilmicin
Defined daily dose
0.35 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

85 interactions on record for netilmicin.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Netilmicin · interactions on record

85 records

  • 28 severe
  • 55 moderate
  • 2 minor

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Netilmicin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All netilmicin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Bulgaria · Нетацин
  • Germany · Nettacin
  • Spain · Netenax
  • France · Anetena
  • Italy · Arqueta, Nettacin
  • Poland · Netenax
  • Portugal · Netenax, Tilcin
  • Romania · Nettacin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94f4162d-27e5-42d5-8e20-9600e30fb192
GET /v1/drugs/94f4162d-27e5-42d5-8e20-9600e30fb192?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.35",
  "form": "injektioneste, liuos",
  "route": null,
  "ddd_unit": "g",
  "strength": "10 mg/ml",
  "atc_label": "netilmisiini",
  "ma_number": "8387",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1526",
  "authorised_at": "1982-09-22"
}

See everything about netilmicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.